Search Results for '3tc dtg'

3tc dtg published presentations and documents on DocSlides.

DTG + 3TC versus DTG + TDF-FTC as Initial ART

DTG + 3TC versus DTG + TDF-FTC as Initial ART

by della

GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...

Switch to DTG/ABC/3TC

Switch to DTG/ABC/3TC

by karlyn-bohler

STRIIVING . Study. Design. Endpoints. Primary: pr...

Switch to DTG/3TC TANGO Design

Switch to DTG/3TC TANGO Design

by lam

Endpoints. Primary: proportion of patients with HI...

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

by jasmine

–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...

DTG/3TC 1st line (GEMINI)

DTG/3TC 1st line (GEMINI)

by oryan

ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

by jacey

1. ViiV Healthcare, Brentford, UK; . 2. Centre Hos...

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

by myesha-ticknor

Martina Penazzato MD, PhD. Paediatric lead, HIV D...

Dolutegravir-Lamivudine (

Dolutegravir-Lamivudine (

by audrey

Dovato. ). Last Updated: November 28, 2022. Prepar...

What’s new in the 2019 WHO Guidelines:

What’s new in the 2019 WHO Guidelines:

by elina

Dolutegravir based regimens in first- ad second-li...

Meg Doherty MD MPH PhD 23 July 2018

Meg Doherty MD MPH PhD 23 July 2018

by jordyn

WHO HQ. The role of DTG based regimens in first- a...

WHO ARV Forecasting Meeting

WHO ARV Forecasting Meeting

by sistertive

Geneva, March 19 - 20 , 2015 1 | Treatment and C...

Comparison of INSTI vs EFV

Comparison of INSTI vs EFV

by mediumgeneral

STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...

1 Fundación Huésped, Buenos Aires, Argentina;

1 Fundación Huésped, Buenos Aires, Argentina;

by aaron

2. Instituto Nacional de Ciencias Médicas y Nutr...

Comparison of INSTI vs PI

Comparison of INSTI vs PI

by conchita-marotz

FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...

DTG vs LPV/r (DAWNING): Efficacy

DTG vs LPV/r (DAWNING): Efficacy

by winnie

by Baseline NRTI Resistance . and Second-Line NRTI...

Cases from the Clinic(ians): Case-based Panel Discussion

Cases from the Clinic(ians): Case-based Panel Discussion

by tripp

Associate Dean for Global Health. University of Al...

HIV 2020: Time for change

HIV 2020: Time for change

by garcia

Dr. Kay Mahomed. Netcare. Garden City Clinic. Ma...

Interactive ART Cases From the Clinic: Is There One Right Answer?

Interactive ART Cases From the Clinic: Is There One Right Answer?

by megan

Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...

Treatment Approaches to Achieve the 2

Treatment Approaches to Achieve the 2

by gabriella

nd. 90: Child Friendly Formulations . Victor Mu...

Updates on Individual and Universal HIV Treatment Strategies

Updates on Individual and Universal HIV Treatment Strategies

by norah

EECA INTERACT, November 19, 2019. Stefan Baral, MD...

Optimization of Antiretroviral Therapy

Optimization of Antiretroviral Therapy

by belinda

With Emergence of Comorbidities. Roger J. . Bedimo...

Thinking of Now and Tomorrow: Emerging Treatment Paradigms

Thinking of Now and Tomorrow: Emerging Treatment Paradigms

by deena

Pedro Cahn. Disclosures. Advisory. . boards. : Me...

HIV History successes and lessons learned

HIV History successes and lessons learned

by linda

PADO-Dr Martina Penazzato MD MSc PhDPaediatricHIV ...

1 Queen Mary University, London, United Kingdom;

1 Queen Mary University, London, United Kingdom;

by trish-goza

1 Queen Mary University, London, United Kingdom; ...

Dolutegravir monotherapy

Dolutegravir monotherapy

by alexa-scheidler

Dolutegravir monotherapy vs. dolutegravir/ abac...

Updated WHO Treatment Guidelines &

Updated WHO Treatment Guidelines &

by mitsue-stanley

Data . from other . cohorts and . regions to guid...

Projecting the Impact of

Projecting the Impact of

by marina-yarberry

Generic. HIV . Drugs. on 90-90-90. Esteban Burr...

Dual Antiretroviral Therapy

Dual Antiretroviral Therapy

by debby-jeon

This program will include a discussion of off-lab...

Highlights for clinical

Highlights for clinical

by pasty-toler

. practice. HIV. International Congress of Drug ...

Rajesh T. Gandhi, MD Director, HIV Clinical Services and Education

Rajesh T. Gandhi, MD Director, HIV Clinical Services and Education

by calandra-battersby

Massachusetts General Hospital. Boston, Massachus...

Treating and Preventing HIV in 2019: Interactive Cases From the Clinic(ians)

Treating and Preventing HIV in 2019: Interactive Cases From the Clinic(ians)

by alida-meadow

Treating and Preventing HIV in 2019: Interactive ...

Joel E. Gallant, MD, MPH

Joel E. Gallant, MD, MPH

by mastervisa

Medical Director, Specialty . Services. Southwest ...

Michael S. Saag , MD Professor of Medicine

Michael S. Saag , MD Professor of Medicine

by roxanne

Associate Dean for Global Health. University of Al...

Cases From the Clinic( ians

Cases From the Clinic( ians

by ImNotABaby

):. Antiretroviral Therapy Cases . and . Panel Dis...

IAS – USA Fall New York Course: Case Discussion

IAS – USA Fall New York Course: Case Discussion

by jalin

Luke . Jerram. Disclosures: Educational grant supp...

Introduction Characteristics, Treatment Patterns,

Introduction Characteristics, Treatment Patterns,

by cappi

and . Virologic. Outcomes . for Treatment-experie...